CLINICAL TRIALS PROFILE FOR NEBUPENT
✉ Email this page to a colleague
All Clinical Trials for NEBUPENT
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02669706 ↗ | Intravenous Pentamidine for Pneumocystis Jirovecii Pneumonia | Completed | University of Illinois at Chicago | 2015-03-01 | The main objective of this study is to assess the safety of administering intravenous (IV) pentamidine for Pneumocystis jirovecii pneumonia (PJP) prophylaxis in adult inpatients with hematologic malignancies and stem cell transplant recipients. There will also be an assessment of patient satisfaction associated with intravenous pentamidine PJP prophylactic therapy. | |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NEBUPENT
Condition Name
Clinical Trial Locations for NEBUPENT
Trials by Country
Clinical Trial Progress for NEBUPENT
Clinical Trial Phase
Clinical Trial Sponsors for NEBUPENT
Sponsor Name